Solvents and Parkinson disease: A systematic review of toxicological and epidemiological evidence

被引:51
作者
Lock, Edward A. [1 ]
Zhang, Jing [3 ]
Checkoway, Harvey [2 ]
机构
[1] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England
[2] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA
关键词
Parkinson's disease; Parkinsonism; Solvents; Trichloroethylene; n-Hexane; Toluene; Neurotoxicology; Epidemiology; SUBCHRONIC TOLUENE EXPOSURE; UBIQUITIN-PROTEASOME SYSTEM; MEDIATED LOCOMOTOR-ACTIVITY; ENVIRONMENTAL RISK-FACTORS; MPTP MOUSE MODEL; OCCUPATIONAL-EXPOSURE; SUBSTANTIA-NIGRA; CARBON-MONOXIDE; NEUROLOGICAL SEQUELAE; MANGANESE EXPOSURE;
D O I
10.1016/j.taap.2012.11.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Parkinson disease (PD) is a debilitating neurodegenerative motor disorder, with its motor symptoms largely attributable to loss of dopaminergic neurons in the substantia nigra. The causes of PD remain poorly understood, although environmental toxicants may play etiologic roles. Solvents are widespread neurotoxicants present in the workplace and ambient environment. Case reports of parkinsonism, including PD, have been associated with exposures to various solvents, most notably trichloroethylene (TCE). Animal toxicology studies have been conducted on various organic solvents, with some, including TCE, demonstrating potential for inducing nigral system damage. However, a confirmed animal model of solvent-induced PD has not been developed. Numerous epidemiologic studies have investigated potential links between solvents and PD, yielding mostly null or weak associations. An exception is a recent study of twins indicating possible etiologic relations with TCE and other chlorinated solvents, although findings were based on small numbers, and dose-response gradients were not observed. At present there is no consistent evidence from either the toxicological or epidemiologic perspective that any specific solvent or class of solvents is a cause of PD. Future toxicological research that addresses mechanisms of nigral damage from TCE and its metabolites, with exposure routes and doses relevant to human exposures, is recommended. Improvements in epidemiologic research, especially with regard to quantitative characterization of long-term exposures to specific solvents, are needed to advance scientific knowledge on this topic. Crown Copyright (C) 2012 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:345 / 355
页数:11
相关论文
共 109 条
[1]   PARKINSONS-DISEASE - PATHOPHYSIOLOGY [J].
AGID, Y .
LANCET, 1991, 337 (8753) :1321-1324
[2]   Basal ganglia neurotoxins [J].
Albin, RL .
NEUROLOGIC CLINICS, 2000, 18 (03) :665-+
[3]   Glutathione-dependent bioactivation of haloalkanes and haloalkenes [J].
Anders, MW .
DRUG METABOLISM REVIEWS, 2004, 36 (3-4) :583-594
[4]   PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING WITH DICHLOROMETHANE, ITS METABOLITE, CARBON-MONOXIDE, AND BLOOD CARBOXYHEMOGLOBIN IN RATS AND HUMANS [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
MACNAUGHTON, MG ;
REITZ, RH ;
NOLAN, RJ ;
MCKENNA, MJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (01) :14-27
[5]   DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase [J].
Andres-Mateos, Eva ;
Perier, Celine ;
Zhang, Li ;
Blanchard-Fillion, Beatrice ;
Greco, Todd M. ;
Thomas, Bobby ;
Ko, Han Seok ;
Sasaki, Masayuki ;
Ischiropoulos, Harry ;
Przedborski, Serge ;
Dawson, Ted M. ;
Dawson, Valina L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (37) :14807-14812
[6]   Pesticide exposure and risk for Parkinson's disease [J].
Ascherio, Alberto ;
Chen, HonPei ;
Weisskopf, Marc G. ;
O'Reilly, Eilis ;
McCullough, Marjorie L. ;
Calle, Eugenia E. ;
Schwarzschild, Michael A. ;
Thun, Michael J. .
ANNALS OF NEUROLOGY, 2006, 60 (02) :197-203
[7]   A review of potential neurotoxic mechanisms among three chlorinated organic solvents [J].
Bale, Ambuja S. ;
Barone, Stan, Jr. ;
Scott, Cheryl Siegel ;
Cooper, Glinda S. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 255 (01) :113-126
[8]   Paraquat and Parkinson's disease [J].
Berry, C. ;
La Vecchia, C. ;
Nicotera, P. .
CELL DEATH AND DIFFERENTIATION, 2010, 17 (07) :1115-1125
[9]   Ubiquitin-proteasome system and Parkinson's diseases [J].
Betarbet, R ;
Sherer, TB ;
Greenamyre, JT .
EXPERIMENTAL NEUROLOGY, 2005, 191 :S17-S27
[10]  
Blandini Fabio, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS124, DOI 10.1016/j.parkreldis.2008.04.015